“Psychedelic-assisted therapies represent a potential new frontier in the treatment of mental health conditions, and our top priority is ensuring there is a path forward to integrate them into the health care system, if FDA approved,” said Amy Emerson, CEO, MAPS PBC. “Strong collaborations like this one demonstrate that by working together, we can move closer to our collective goal of helping people currently underserved by existing treatments for mental health conditions.”
Originally appearing here (Archived)
